H.R. 5763 · 114th Congress
Prostate Cancer Misdiagnosis Elimination Act of 2016
- Stage
- In committee
- Sponsor
- Larry Bucshon
- Introduced
- 2016-07-13
- Latest action
- 2016-08-01 · Referred to the Subcommittee on Health.
Summary
Prostate Cancer Misdiagnosis Elimination Act of 2016
This bill specifies that, unless the physician ordering a DNA Specimen Provenance Assay (DSPA) test recommends otherwise, a DSPA test furnished with respect to a positive prostate cancer biopsy shall be deemed to be medically necessary for purposes of Medicare.